Volini

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Volini

Quick Facts

Property Description
Active ingredient Diclofenac
Form Gel, Spray, Liniment, Emulgel
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use Localized pain relief, reduction of inflammation
Origin Synthetic compound

What Type of Medicine is Volini?

Volini is a recognized trade name for a topical Diclofenac preparation, which is categorically defined as a Nonsteroidal Anti-Inflammatory Drug (NSAID). This product is a synthetic compound specifically administered via the cutaneous route, prioritizing a concentrated therapeutic effect at the site of application. The formulation is primarily distinguished by its rapid absorption properties, often offered as a spray or Emulgel, designed for efficient skin penetration. Unlike oral NSAIDs, the goal of this topical formulation is to deliver the active drug, Diclofenac, locally to manage inflammation and pain near the skin's surface.

Composition and Available Forms

The product's essential therapeutic agent is the single active ingredient, Diclofenac, often formulated as Diclofenac Diethylamine to optimize its transdermal delivery. This specialized topical formulation is available in various dosage forms, including the familiar Gel and the contact-free Spray, each utilizing a distinct base/vehicle to facilitate skin permeation. These topical formulations are designed to deliver the analgesic agent to underlying soft tissues.

General Purpose and Action for Pain Relief

The general therapeutic purpose of this preparation is to provide effective pain relief through a dual action: a localized anti-inflammatory effect and a strong peripheral analgesic effect. The product works by concentrating the NSAID action where symptoms originate, directly mitigating pain and inflammation. This localized action primarily benefits symptoms associated with common musculoskeletal disorders and discomfort from soft tissue injuries, providing a focused, non-systemic approach to targeted pain management.

What side effects are possible with Volini?

Possible Side Effects and Safety Information

The official safety profile for topical Diclofenac is primarily defined by local reactions at the application site, but the labeling also includes the serious systemic risks associated with the Nonsteroidal Anti-Inflammatory Drug (NSAID) class.


Adverse Reaction Classification

Side effects are officially classified by regulatory documents according to their frequency:

  • Common (affecting up to 1 in 10 people): Reactions are mainly dermatological, including dermatitis (contact dermatitis), pruritus (itching), rash, and erythema (redness).
  • Very Rare (affecting fewer than 1 in 10,000 people): These include severe reactions such as photosensitivity (increased sun sensitivity), asthma, or generalized hypersensitivity reactions (e.g., angioedema).

Serious Systemic Safety Considerations

Despite minimal systemic absorption, the labeling carries mandatory warnings for the potential for serious adverse events associated with all NSAIDs. These rare but significant risks include cardiovascular thrombotic events (such as myocardial infarction and stroke) and severe gastrointestinal complications (bleeding, ulceration, or perforation).


Time-Related Patterns and Restrictions

Regulatory documents note that the risk of systemic adverse events may increase with duration of use or if the product is applied to very large areas of the skin. Use is contraindicated during the third trimester of pregnancy due to the potential risk of fetal harm. The product is also restricted from use on broken or non-intact skin and by individuals with known hypersensitivity to aspirin or other NSAIDs.

Overdose and Emergency Response

Overdose and when to seek help

Overdose from this topical Diclofenac preparation is considered unlikely under normal use due to low systemic absorption. However, accidental ingestion or significantly excessive topical application can result in systemic effects consistent with an oral Nonsteroidal Anti-Inflammatory Drug (NSAID) overdose.


Documented Overdose Manifestations

Official regulatory labeling indicates that overdose may present with gastrointestinal distress (e.g., nausea, vomiting, abdominal pain) and central nervous system effects such as drowsiness, dizziness, headache, and tinnitus. Serious outcomes listed include gastrointestinal bleeding, renal injury, hepatotoxicity, and the potential for cardiovascular thrombotic events (e.g., heart attack or stroke). In very severe scenarios, seizures or coma may be documented.


Mandatory Emergency Actions

Regulatory sources require seeking emergency medical help right away if you experience signs of a serious cardiovascular event (such as chest pain or slurred speech) or an anaphylactic reaction (swelling, difficulty breathing). The medication must be stopped immediately if signs of GI bleeding occur. No specific antidote is known, meaning management is symptomatic and supportive. Elderly patients are recognized as a population at heightened risk for serious gastrointestinal and renal events following systemic exposure.

Therapeutic Uses of Volini

What Volini Treats: Main Uses and Benefits

The medication Volini is a topical preparation and is considered relevant for symptomatic relief of musculoskeletal discomfort. Its application is relevant across domains where short-term symptomatic assistance is needed to address acute, localized symptoms.

This medication is applied in addressing symptoms related to physical discomfort such as pain, swelling, inflammation, and stiffness. It is generally used across conditions presenting with acute episodes, including minor sprains, strains, and localized forms of soft tissue rheumatism.

The core benefit is focused on temporary comfort during symptomatic flare-ups:

“It provides supportive relief when symptoms create noticeable functional strain.”

Common Symptomatic Domains

The gel is relevant for managing symptom clusters that may become disruptive, offering relief for:

  • Muscle and Joint Aches: Addressing localized pain in areas like the back, neck, shoulders, and knees.
  • Swelling and Tenderness: Easing manifestations related to inflammatory or irritative states associated with acute or disruptive episodes.
  • Restricted Movement: Assisting with symptoms of stiffness and temporary tightness, which may help patients cope more steadily with symptom fluctuations.

This approach assists with maintaining functional stability, contributing to improved day-to-day comfort during symptomatic periods.


Quick Fact: Relief for Localized Discomfort

This medication is applied in situations involving certain distressing symptoms that are confined to a specific area of the body, which helps provide supportive relief in conditions marked by increased physiological stress.

Regulatory References

  1. NIH DailyMed overview

Eligibility and Restrictions for Use

Official Eligibility and Contraindications for Volini Gel

Volini Gel, which contains the non-steroidal anti-inflammatory drug (NSAID) diclofenac, has specific population restrictions defined in regulatory documents.

Contraindicated Populations (Must NOT Use):

Contraindication Affected Group
Hypersensitivity Patients allergic to diclofenac, aspirin, other NSAIDs, or any component of the gel.
Allergy History Individuals who have had asthma, urticaria (hives), or acute rhinitis precipitated by aspirin or other NSAIDs.
Pregnancy Women in the third trimester of pregnancy (due to risk of fetal harm).
Age Children and adolescents under 14 years old (due to insufficient safety and efficacy data).

Restricted or Conditional Use:

  • Skin Condition: The gel must be applied only to intact, non-diseased skin and must not contact open wounds, injuries, eyes, or mucous membranes.
  • Organ Function: Use requires caution in patients with reduced cardiac, renal, or hepatic function and should be avoided in those with severe organ impairment.
  • Concomitant Use: Patients using oral NSAIDs concurrently should exercise caution due to increased risk of systemic side effects.
  • Breastfeeding: Not generally recommended, and the gel must never be applied to the breasts of nursing mothers.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Volini is a topical Diclofenac preparation, and its regulatory profile includes documented interaction considerations that primarily reflect the risks associated with the Nonsteroidal Anti-Inflammatory Drug (NSAID) class, despite low systemic absorption. Official regulatory documents list specific drug interactions and necessary administration constraints.


Contraindicated and Avoided Combinations

Use is contraindicated for managing pain in the peri-operative setting of Coronary Artery Bypass Graft (CABG) surgery. Co-administration with oral NSAIDs or analgesic doses of aspirin should be avoided due to the potential for increased adverse effects.


Systemic Pharmacodynamic Interactions

The preparation may interact with agents affecting blood pressure and coagulation. Concomitant use with anticoagulants (such as Warfarin) or antiplatelet agents may increase the risk of bleeding events. Furthermore, regulatory labels state that the efficacy of ACE Inhibitors, ARBs, Beta-Blockers, and Diuretics may be diminished.


Exposure-Modifying Effects and Constraints

Diclofenac may cause a pharmacokinetic interaction leading to an increase in the serum concentration and prolongation of the half-life of Digoxin. A timing-based administration constraint exists for local application: other topical products, including sunscreens and lotions, must not be applied to the treated skin area until the Diclofenac preparation is fully dry. The potential for renal function deterioration is heightened when combined with ACE Inhibitors or ARBs in elderly, volume depleted, or renally impaired patients.

Mechanism of Action

The action involves two primary mechanistic pathways: biochemical enzyme inhibition and rapid sensory nerve modulation, both localized to peripheral tissues.

Local Suppression of Inflammatory Mediators

The foundational mechanism relies on the active ingredient, Diclofenac, acting as a preferential inhibitor of the Cyclooxygenase-2 (COX-2) enzyme. By blocking this enzyme, the preparation directly limits the synthesis of prostaglandins (PGE₂), which function as key chemical messengers that sensitize peripheral pain-transmitting nerves and drive local vascular responses. This molecular cascade results in a reduced local concentration of key inflammatory mediators, modulating the corresponding physiological response and limiting PGE₂-mediated increases in vascular permeability and local fluid accumulation.


️ Rapid Modulation of Peripheral Pain Signaling

Complementary components like Menthol and Methyl Salicylate engage a distinct mechanism of sensory modulation. Menthol stimulates cold-sensitive TRPM8 receptors on peripheral nerve endings, while Methyl Salicylate acts as a chemical irritant. This dual interaction rapidly interferes with and desensitizes the nociceptive signaling pathways, providing an immediate sensory input that physiologically interferes with or overrides the transmission of signals from deeper nociceptors. This sensory modulation governs the kinetic characteristics of the initial physiological response.

Dosage and Administration Information

The instructions for using topical analgesic gels, such as Volini, which contain non-steroidal anti-inflammatory drugs (NSAIDs) like Diclofenac, are designed to maximize local absorption while minimizing systemic exposure.

General Application Guidelines

Guideline Instruction
Application Apply the gel only to clean, dry, unbroken skin. Do not use on open wounds, cuts, infections, or rashes.
Dosage The amount of gel required is typically a small, measured amount (often 2 to 4 grams, depending on the area) to cover the affected site. Always follow the specific dosing card or physician's instructions if provided.
Frequency The gel is commonly applied to the affected area three to four times a day. Allow several hours between applications and do not exceed the maximum daily usage outlined on the product label or by a healthcare professional.
Massage Gently rub the gel completely into the skin using your hand.
Hand Washing Wash your hands thoroughly with soap and water immediately after application, unless the treatment area is the hands themselves. If treating the hands, do not wash the area for at least one hour after applying the gel.

Wait at least 10 minutes before covering the treated skin with clothing or gloves. Avoid showering or bathing for at least one hour after application. Do not apply a bandage over the treated area or use external heat (such as a heating pad) on the site, as this can increase systemic absorption and potential risk.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Topical Diclofenac


Evidence for Acute Pain from Minor Sprains and Strains

The evidence base for topical diclofenac in the context of acute episodes of muscle and joint discomfort relies on short-term Randomized Controlled Trials (RCTs) and systematic reviews. These studies typically included adults who experienced acute, localized soft tissue injuries. Researchers applied the medication or an inactive topical vehicle and monitored patient-reported outcomes describing perceived discomfort, such as pain intensity and tenderness on pressure, over short follow-up durations (typically seven to fourteen days). The scientific literature describes patterns observed in the studies, where measurements of pain change were monitored over these short time frames.


Evidence for Chronic Pain Associated with Osteoarthritis

Research into the use of topical diclofenac for chronic joint pain, primarily associated with osteoarthritis (OA) of the knee and hand, has been evaluated in intermediate-term RCTs lasting up to 12 weeks. Studies explored the treatment of conditions characterized by functional limitations and monitored outcomes reflecting daily functioning, such as the WOMAC Index. Findings describe patterns observed in the studies related to change in these functional measures compared to the inactive topical vehicle. It is noted that the response to the topical placebo was associated with perceived discomfort change in some chronic pain studies, and the research is primarily focused on knee OA.


Research Gaps and Uncertainties

While the evidence is established for acute sprains and knee OA, several research limitation frames exist. For instance, the long-term effects are not fully established through extensive randomized trials lasting a year or more, and follow-up durations are limited. Additionally, comparative evidence is lacking between this specific topical formulation and many other similar topical products. Data for certain patient groups, such as children and adolescents, remain insufficient or absent in the primary clinical trials.

Key Studies & References

  1. Diclofenac Diethylamine Topical Gel 1% (Voltaren Gel) Official FDA Label and Patient Information
  2. American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
  3. Diclofenac Topical - MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Volini (FAQ)

Q: How quickly does Volini start working for pain relief?

Studies and official information indicate that pain relief may begin within a few hours of application. Studies have reported an associated quicker return to movement, with some data showing a measurable decrease in pain on movement within the first few days of treatment.

Q: How long does the relief from a single application of Volini typically last?

According to the official product information for some versions, sustained pain relief is provided for up to 12 hours when applied twice daily. This information indicates the general duration of expected effect.

Q: Is Volini safe to use during pregnancy? (Informational only)

Regulatory documents state that use of the active ingredient, diclofenac, is contraindicated (must not be used) during the third trimester of pregnancy. For the first and second trimesters, use is generally not recommended unless a healthcare provider deems it clearly necessary, due to potential risks to the fetus.

Q: Can I apply a bandage or heat pack after using Volini?

Official warnings advise that covering the treated area with an airtight occlusive dressing or external heat (such as a heating pad) should be avoided. This constraint is in place because heat and airtight dressings can significantly increase the systemic absorption of the active ingredient, raising the potential for systemic risks.

Q: Can I use Volini if I have sensitive skin?

Official product information notes that the gel contains excipients like Propylene glycol, which may cause mild, localized skin irritation. For this reason, regulatory information suggests discontinuing the product at the first sign of a rash or other hypersensitivity reaction.

Q: Can the ingredients in Volini penetrate deep into the muscle?

Studies show that the active ingredient accumulates in the skin and is released into the underlying tissue and concentrates in inflamed areas such as joints. This process is designed to deliver the drug to the targeted tissues while minimizing amounts circulating in the bloodstream.

Q: Should other topical products, like sunscreens or lotions, be applied at the same time as Volini?

Regulatory warnings advise that other topical products, including sunscreens and cosmetics, must not be applied to the treated skin area until the Diclofenac preparation is fully dry. This constraint helps manage the overall absorption and potential systemic exposure to the active ingredient.

Q: Does Volini require a prescription?

The need for a prescription depends on the specific concentration and local regulations. In many jurisdictions, lower strength diclofenac topical gels (e.g., 1%) are commonly available over-the-counter (OTC), while higher concentrations may require a prescription.

Q: What happens if I use too much Volini?

Official documents state that due to the low systemic absorption with topical use, an overdose is considered unlikely. If the dose is significantly exceeded, regulatory guidance indicates the gel should be removed from the skin and washed off with water.

Q: How often can Volini generally be applied?

Regulatory documents state the gel is generally applied to the affected area multiple times a day. The specific recommended frequency depends on the product strength and formulation, which is detailed on the individual product's label.

Q: Why does Volini sometimes feel cool or warm on the skin?

The feeling of coolness is attributed to the aqueous-alcoholic base in the gel formulation. Other complementary ingredients, such as Menthol, work by rapidly engaging nerve endings in the skin, which creates a sensory input often perceived as a cooling or tingling sensation.

Q: Does Volini enter the bloodstream?

Yes, a small amount of the active ingredient enters the bloodstream. However, the plasma concentrations (the amount in the blood) achieved are significantly lower than those following oral administration of diclofenac.

Q: Can Volini be used for chronic pain conditions?

Official documents indicate the product is used for the local symptomatic relief of pain and inflammation in localized forms of soft tissue rheumatism and chronic signs and symptoms of osteoarthritis of the joints.

Q: Is it normal to feel a tingling sensation after applying Volini?

A mild tingling or cooling sensation is expected as part of the action of the formula's excipients. However, a burning sensation at the application site is listed in regulatory documents as a possible undesirable effect.

Q: Can Volini be used on the neck or head?

The product is directed for use on the painful or inflamed area, but it must be applied only to intact, non-diseased skin. It is critically important that the gel is kept away from the eyes or mucous membranes.

Q: Can Volini be used long-term?

Official guidelines state that the product is not intended for use for more than 7 days for pain relief without medical oversight. Systemic adverse effects are possible if the product is used over a prolonged period or applied to very large areas of the skin.

Q: Why is it important to wash hands after using Volini?

Hand washing is required immediately after application (unless the hands are the treatment site) to prevent the accidental transfer of the gel to sensitive areas, such as the eyes or mucous membranes.

Q: Does the application of Volini affect sun exposure?

Photosensitivity reaction (increased sensitivity to sunlight or tanning devices) is listed as a very rare undesirable effect. Regulatory documents advise patients to avoid excessive sun exposure to reduce this risk.

Q: Are there different strengths or versions of Volini available?

Yes, topical diclofenac is available in different concentrations and forms, such as gels and sprays. Official product labeling indicates various strengths, including concentrations equivalent to 1% and 2% diclofenac sodium, depending on the region.

Q: What information is available regarding Volini and breastfeeding? (Informational only)

Regulatory documents indicate that the active ingredient, diclofenac, passes into breast milk in small amounts. Although effects on the suckling child are not anticipated at therapeutic doses, regulatory documents state the gel should not be applied to the breasts of nursing mothers.

Q: Does using Volini affect driving or operating machinery?

Official regulatory documents for topical diclofenac often state 'None known' regarding effects on the ability to drive and use machines, as topical application leads to very low systemic absorption.

How should Volini be stored and disposed of?

How to Store and Dispose of Volini Gel

Official regulatory documents define specific conditions for the storage and disposal of Volini Gel (topical Diclofenac) to maintain its stability and ensure environmental safety.


Storage Requirements

The gel must be stored at a temperature below 30 C and protected from light. It is essential not to freeze the product. The medicine must be kept in its original container and stored out of the sight and reach of children. The labeled shelf-life for the unopened product is typically 36 months.


Disposal Instructions

Any unused product or waste material must be disposed of strictly in accordance with local requirements. Due to the active ingredient's risk to the aquatic environment, the product should not be discharged into drains or wastewater. Excess gel should be wiped off with a paper towel and discarded in the residual household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Volini found in:

A-Z Index: